Jozef Michalik
Overview
Explore the profile of Jozef Michalik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
46
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Szilasiova J, Gazda J, Cimprichova A, Cvengrosova A, Donath V, Fedicova M, et al.
Neurol Res
. 2021 Jul;
44(1):38-46.
PMID: 34261427
Objective: : Neuromyelitis optica spectrum disorders (NMOSDs) are a group of rare, inflammatory, demyelinating diseases that affect the central nervous system. Neither the incidence nor the prevalence of NMOSD has...
2.
Kalmarova K, Kurca E, Sivak S, Michalik J, Plank L, Vysehradsky R, et al.
Sarcoidosis Vasc Diffuse Lung Dis
. 2020 Jun;
36(1):79-85.
PMID: 32476939
Sarcoidosis is a granulomatous multisystemic disease of unknown cause most often affecting the lungs, lymph nodes of the pulmonary hilus, eyes, skin, and other structures including central (CNS) or peripheral...
3.
cierny D, Michalik J, Dubovan P, Skerenova M, Javor J, Kurca E, et al.
J Neuroimmunol
. 2019 Mar;
330:123-129.
PMID: 30875612
In this study, we analysed the association of rs703842 in CYP27B1 gene with multiple sclerosis (MS) risk and disability progression in a group of 496 MS patients and 521 controls....
4.
Grofik M, Sivak S, Nosal V, Koprusakova M, Michalik J, cierny D, et al.
J Neurol Sci
. 2018 Aug;
392:28-31.
PMID: 30097148
No abstract available.
5.
Javor J, Shawkatova I, Durmanova V, Parnicka Z, cierny D, Michalik J, et al.
Int J Immunogenet
. 2018 Jul;
PMID: 30009568
Tumour necrosis factor (TNF)-mediated signalling plays a key role in inflammatory and neurodegenerative processes leading to the development of multiple sclerosis (MS). Recent studies have highlighted the role of tumour...
6.
cierny D, Lehotsky J, Kantorova E, Sivak S, Javor J, Kurca E, et al.
Neurol Res
. 2018 Apr;
40(7):607-614.
PMID: 29619906
Objective: The aim of our present study was to analyse the association of HLA-DRB1 and -DQB1 alleles and genotypes with Multiple Sclerosis (MS) disability progression in a cohort of Central...
7.
Shawkatova I, Javor J, Parnicka Z, Bucova M, copikova-Cudrakova D, Michalik J, et al.
Folia Microbiol (Praha)
. 2017 Jan;
62(4):287-293.
PMID: 28130760
Infiltration of immune cells into CNS is one of the essential events in multiple sclerosis (MS) development. Adhesion molecules like the intercellular adhesion molecule 1 (ICAM-1) play critical role in...
8.
cierny D, Michalik J, Skerenova M, Kantorova E, Sivak S, Javor J, et al.
Neurol Res
. 2016 Jun;
38(8):678-84.
PMID: 27338176
Objective: Vitamin D acts through vitamin D receptor (VDR) and has promising beneficial effects in the development and progression of multiple sclerosis (MS). The purpose of our study was to...
9.
Sivak S, Kantorova E, Kurca E, Marcinek J, Slavik P, Michalik J, et al.
BMC Cancer
. 2016 Mar;
16:182.
PMID: 26944049
Background: Primary diffuse leptomeningeal gliomatosis (PDLG) is a very rare neuro-oncological disease, with only 90 cases of PDLG described in medical literature so far. Case Presentation: We present a case...
10.
Michalik J, cierny D, Kantorova E, Kantarova D, Juraj J, Parnicka Z, et al.
Neurol Res
. 2016 Jan;
37(12):1060-7.
PMID: 26744784
Objective: The aim of the present study was to assess the association between HLA-DRB1 and -DQB1 allele groups with the genetic predisposition to multiple sclerosis (MS) in the Caucasian Central...